ReP USP - Resultado da busca

Artigo de periodico
Fluoxetine alters rat's milk properties causing impact on offspring's development (2024)
Abreu, Gabriel Ramos de ; Magalhães, Julia Zaccarelli ; Féba, Laís Stephano; Penna, Emily Yashima; Silva, Julia Prado da; Teixeira, Mariana Vespar; Manes, Marianna ; Vergara, Guilherme A; Rodrigues, Leonardo M. A; Fukushima, André Rinaldi ; Ricci, Esther Lopes ; Spinosa, Helenice de Souza
Source: Toxicology and Applied Pharmacology. Unidade: FMVZ
Subjects: ANTIDEPRESSIVOS, DEPRESSÃO PÓS-PARTO, LEITE MATERNO, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABREU, Gabriel Ramos de et al. Fluoxetine alters rat's milk properties causing impact on offspring's development. Toxicology and Applied Pharmacology, v. 483, p. 1-10, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.taap.2024.116805. Acesso em: 16 nov. 2024.
APA
Abreu, G. R. de, Magalhães, J. Z., Féba, L. S., Penna, E. Y., Silva, J. P. da, Teixeira, M. V., et al. (2024). Fluoxetine alters rat's milk properties causing impact on offspring's development. Toxicology and Applied Pharmacology, 483, 1-10. doi:10.1016/j.taap.2024.116805
NLM
Abreu GR de, Magalhães JZ, Féba LS, Penna EY, Silva JP da, Teixeira MV, Manes M, Vergara GA, Rodrigues LMA, Fukushima AR, Ricci EL, Spinosa H de S. Fluoxetine alters rat's milk properties causing impact on offspring's development [Internet]. Toxicology and Applied Pharmacology. 2024 ; 483 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.taap.2024.116805
Vancouver
Abreu GR de, Magalhães JZ, Féba LS, Penna EY, Silva JP da, Teixeira MV, Manes M, Vergara GA, Rodrigues LMA, Fukushima AR, Ricci EL, Spinosa H de S. Fluoxetine alters rat's milk properties causing impact on offspring's development [Internet]. Toxicology and Applied Pharmacology. 2024 ; 483 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.taap.2024.116805
Artigo de periodico
Agomelatine inhibits platelet aggregation through melatonin receptor-dependent and independent mechanisms (2023)
Vicente, Julia Modesto ; Lescano, Caroline Honaiser ; Monica, Fabiola Zakia ; Gobbi, Gabriella ; Anhê, Gabriel Forato ; Bordin, Silvana
Source: Life Sciences. Unidade: ICB
Subjects: MELATONINA, PLAQUETAS SANGUÍNEAS, COLÁGENO, TROMBOXANOS, ANTIDEPRESSIVOS, CÁLCIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICENTE, Julia Modesto et al. Agomelatine inhibits platelet aggregation through melatonin receptor-dependent and independent mechanisms. Life Sciences, v. 328, p. 14 , 2023Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2023.121906. Acesso em: 16 nov. 2024.
APA
Vicente, J. M., Lescano, C. H., Monica, F. Z., Gobbi, G., Anhê, G. F., & Bordin, S. (2023). Agomelatine inhibits platelet aggregation through melatonin receptor-dependent and independent mechanisms. Life Sciences, 328, 14 . doi:10.1016/j.lfs.2023.121906
NLM
Vicente JM, Lescano CH, Monica FZ, Gobbi G, Anhê GF, Bordin S. Agomelatine inhibits platelet aggregation through melatonin receptor-dependent and independent mechanisms [Internet]. Life Sciences. 2023 ; 328 14 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2023.121906
Vancouver
Vicente JM, Lescano CH, Monica FZ, Gobbi G, Anhê GF, Bordin S. Agomelatine inhibits platelet aggregation through melatonin receptor-dependent and independent mechanisms [Internet]. Life Sciences. 2023 ; 328 14 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2023.121906
Artigo de periodico
Influence of genetic polymorphisms on the pharmacokinetics of trazodone hydrochloride: a scoping review and future perspective (2023)
Meulman, Jessica; Visacri, Marilia Berlofa ; Moriel, Patricia ; Pincinato, Eder de Carvalho
Source: Therapeutic Drug Monitoring. Unidade: FCF
Subjects: ANTIDEPRESSIVOS, POLIMORFISMO, FARMACOGENÉTICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEULMAN, Jessica et al. Influence of genetic polymorphisms on the pharmacokinetics of trazodone hydrochloride: a scoping review and future perspective. Therapeutic Drug Monitoring, v. 45, n. 4, p. 479-486, 2023Tradução . . Disponível em: https://doi.org/10.1097/FTD.0000000000001049. Acesso em: 16 nov. 2024.
APA
Meulman, J., Visacri, M. B., Moriel, P., & Pincinato, E. de C. (2023). Influence of genetic polymorphisms on the pharmacokinetics of trazodone hydrochloride: a scoping review and future perspective. Therapeutic Drug Monitoring, 45( 4), 479-486. doi:10.1097/FTD.0000000000001049
NLM
Meulman J, Visacri MB, Moriel P, Pincinato E de C. Influence of genetic polymorphisms on the pharmacokinetics of trazodone hydrochloride: a scoping review and future perspective [Internet]. Therapeutic Drug Monitoring. 2023 ; 45( 4): 479-486.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1097/FTD.0000000000001049
Vancouver
Meulman J, Visacri MB, Moriel P, Pincinato E de C. Influence of genetic polymorphisms on the pharmacokinetics of trazodone hydrochloride: a scoping review and future perspective [Internet]. Therapeutic Drug Monitoring. 2023 ; 45( 4): 479-486.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1097/FTD.0000000000001049
Artigo de periodico
Serotonin Syndrome: The role of pharmacology in understanding its occurrence (2023)
Poian, Leila R. ; Chiavegatto, Silvana
Source: Cureus. Unidade: ICB
Subjects: FARMACOLOGIA, SEROTONINA, ANTIDEPRESSIVOS, FÁRMACOS (SISTEMA NERVOSO PERIFÉRICO), FÁRMACOS (SISTEMA NERVOSO CENTRAL), NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POIAN, Leila R. e CHIAVEGATTO, Silvana. Serotonin Syndrome: The role of pharmacology in understanding its occurrence. Cureus, v. 15, n. 5, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.7759%2Fcureus.38897. Acesso em: 16 nov. 2024.
APA
Poian, L. R., & Chiavegatto, S. (2023). Serotonin Syndrome: The role of pharmacology in understanding its occurrence. Cureus, 15( 5), 1-17. doi:10.7759%2Fcureus.38897
NLM
Poian LR, Chiavegatto S. Serotonin Syndrome: The role of pharmacology in understanding its occurrence [Internet]. Cureus. 2023 ; 15( 5): 1-17.[citado 2024 nov. 16 ] Available from: https://doi.org/10.7759%2Fcureus.38897
Vancouver
Poian LR, Chiavegatto S. Serotonin Syndrome: The role of pharmacology in understanding its occurrence [Internet]. Cureus. 2023 ; 15( 5): 1-17.[citado 2024 nov. 16 ] Available from: https://doi.org/10.7759%2Fcureus.38897
Artigo de periodico
Amitriptyline efficacy in decreasing implant-induced foreign body reaction (2023)
Scheuermann, Karina; Viana, Celso Tarso Rodrigues ; Reis, Diego Carlos dos ; Lazari, Marcela Guimarães Takahashi de ; Orellano, Laura Alejandra Ariza ; Machado, Clara Tolentino; Santos, Leticia Cristine Cardoso dos; Ulrich, Henning ; Capettini, Luciano Santos Aggum; Andrade, Silvia Passos; Campos, Paula Peixoto
Source: IUBMB Life. Unidade: IQ
Subjects: ANTIDEPRESSIVOS, SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHEUERMANN, Karina et al. Amitriptyline efficacy in decreasing implant-induced foreign body reaction. IUBMB Life, v. 75, n. 9, p. 732-742, 2023Tradução . . Disponível em: https://doi.org/10.1002/iub.2725. Acesso em: 16 nov. 2024.
APA
Scheuermann, K., Viana, C. T. R., Reis, D. C. dos, Lazari, M. G. T. de, Orellano, L. A. A., Machado, C. T., et al. (2023). Amitriptyline efficacy in decreasing implant-induced foreign body reaction. IUBMB Life, 75( 9), 732-742. doi:10.1002/iub.2725
NLM
Scheuermann K, Viana CTR, Reis DC dos, Lazari MGT de, Orellano LAA, Machado CT, Santos LCC dos, Ulrich H, Capettini LSA, Andrade SP, Campos PP. Amitriptyline efficacy in decreasing implant-induced foreign body reaction [Internet]. IUBMB Life. 2023 ; 75( 9): 732-742.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/iub.2725
Vancouver
Scheuermann K, Viana CTR, Reis DC dos, Lazari MGT de, Orellano LAA, Machado CT, Santos LCC dos, Ulrich H, Capettini LSA, Andrade SP, Campos PP. Amitriptyline efficacy in decreasing implant-induced foreign body reaction [Internet]. IUBMB Life. 2023 ; 75( 9): 732-742.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/iub.2725
Artigo de periodico
Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study (2023)
Forgerini, Marcela ; Schiavo, Geovana ; Urbano, Gustavo ; Nadai, Tales Rubens de ; Zapata-Cachafeiro, Maruxa ; Herdeiro, Maria Teresa Ferreira ; Mastroianni, Patrícia de Carvalho
Source: Clinical Therapeutics. Unidades: FOB, FMRP
Subjects: FÁRMACOS, ANTIDEPRESSIVOS, HEMORRAGIA, SISTEMA GASTROINTESTINAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORGERINI, Marcela et al. Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study. Clinical Therapeutics, v. 45, n. 7, p. e159-e166, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2023.04.010. Acesso em: 16 nov. 2024.
APA
Forgerini, M., Schiavo, G., Urbano, G., Nadai, T. R. de, Zapata-Cachafeiro, M., Herdeiro, M. T. F., & Mastroianni, P. de C. (2023). Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study. Clinical Therapeutics, 45( 7), e159-e166. doi:10.1016/j.clinthera.2023.04.010
NLM
Forgerini M, Schiavo G, Urbano G, Nadai TR de, Zapata-Cachafeiro M, Herdeiro MTF, Mastroianni P de C. Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study [Internet]. Clinical Therapeutics. 2023 ; 45( 7): e159-e166.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.clinthera.2023.04.010
Vancouver
Forgerini M, Schiavo G, Urbano G, Nadai TR de, Zapata-Cachafeiro M, Herdeiro MTF, Mastroianni P de C. Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study [Internet]. Clinical Therapeutics. 2023 ; 45( 7): e159-e166.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.clinthera.2023.04.010
Artigo de periodico
Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality (2023)
Gabriel, Franciele Cordeiro ; Stein, Airton Tetelbom ; Melo, Daniela Oliveira de ; Mota, Gessica Caroline Henrique Fontes ; Santos, Itamires Benício dos ; Rodrigues, Camila da Silva; Dourado, Andrea; Rodrigues, Mônica Cristiane; Fraguas Junior, Renerio ; Florez, Ivan D ; Correia, Diogo Telles ; Ribeiro, Eliane
Source: Plos One. Unidades: FM, FCF
Subjects: DEPRESSÃO, ANTIDEPRESSIVOS, REVISÃO SISTEMÁTICA, DIRETRIZES PARA A PRÁTICA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABRIEL, Franciele Cordeiro et al. Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality. Plos One, v. 18, n. 2 p. 1-10 art. e0281501, 2023Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0281501. Acesso em: 16 nov. 2024.
APA
Gabriel, F. C., Stein, A. T., Melo, D. O. de, Mota, G. C. H. F., Santos, I. B. dos, Rodrigues, C. da S., et al. (2023). Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality. Plos One, 18( 2 p. 1-10 art. e0281501). doi:10.1371/journal.pone.0281501
NLM
Gabriel FC, Stein AT, Melo DO de, Mota GCHF, Santos IB dos, Rodrigues C da S, Dourado A, Rodrigues MC, Fraguas Junior R, Florez ID, Correia DT, Ribeiro E. Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality [Internet]. Plos One. 2023 ; 18( 2 p. 1-10 art. e0281501):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1371/journal.pone.0281501
Vancouver
Gabriel FC, Stein AT, Melo DO de, Mota GCHF, Santos IB dos, Rodrigues C da S, Dourado A, Rodrigues MC, Fraguas Junior R, Florez ID, Correia DT, Ribeiro E. Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality [Internet]. Plos One. 2023 ; 18( 2 p. 1-10 art. e0281501):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1371/journal.pone.0281501
Artigo de periodico
6-NitroDopamine is an endogenous modulator of rat heart chronotropism (2022)
Britto Júnior, José ; Oliveira, Mariana Gonçalves de ; Gati, Carolina dos Reis; Campos, Rafael ; Moraes, Manoel Odorico ; Moraes, Maria Elisabete A. ; Mónica, Fabíola Zakia ; Antunes, Edson ; De Nucci, Gilberto
Source: Life Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, FREQUÊNCIA CARDÍACA, ÁTRIOS DO CORAÇÃO, RECEPTORES ADRENÉRGICOS, RECEPTORES DE DOPAMINA, RECEPTORES DE CATECOLAMINA, ESPECTROMETRIA DE MASSAS, ANTIDEPRESSIVOS, RATOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITTO JÚNIOR, José et al. 6-NitroDopamine is an endogenous modulator of rat heart chronotropism. Life Sciences, v. 307, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.120879. Acesso em: 16 nov. 2024.
APA
Britto Júnior, J., Oliveira, M. G. de, Gati, C. dos R., Campos, R., Moraes, M. O., Moraes, M. E. A., et al. (2022). 6-NitroDopamine is an endogenous modulator of rat heart chronotropism. Life Sciences, 307, 1-10. doi:10.1016/j.lfs.2022.120879
NLM
Britto Júnior J, Oliveira MG de, Gati C dos R, Campos R, Moraes MO, Moraes MEA, Mónica FZ, Antunes E, De Nucci G. 6-NitroDopamine is an endogenous modulator of rat heart chronotropism [Internet]. Life Sciences. 2022 ; 307 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2022.120879
Vancouver
Britto Júnior J, Oliveira MG de, Gati C dos R, Campos R, Moraes MO, Moraes MEA, Mónica FZ, Antunes E, De Nucci G. 6-NitroDopamine is an endogenous modulator of rat heart chronotropism [Internet]. Life Sciences. 2022 ; 307 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2022.120879
Artigo de periodico
Spontaneous resolution of RS-fluoxetine to a racemic conglomerate upon salt formation with oxalic acid (2022)
Carvalho Junior, Paulo de S ; Diniz, Luan F. ; Cardoso, Teófilo Fernando Mazon; Silva, Cecília Carolina Pinheiro da ; Ellena, Javier
Source: Crystal Growth and Design. Unidade: IFSC
Subjects: CRISTALOGRAFIA, PLANEJAMENTO DE FÁRMACOS, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO JUNIOR, Paulo de S et al. Spontaneous resolution of RS-fluoxetine to a racemic conglomerate upon salt formation with oxalic acid. Crystal Growth and Design, v. 22, n. 10, p. 5966-5973, 2022Tradução . . Disponível em: https://doi.org/10.1021/acs.cgd.2c00599. Acesso em: 16 nov. 2024.
APA
Carvalho Junior, P. de S., Diniz, L. F., Cardoso, T. F. M., Silva, C. C. P. da, & Ellena, J. (2022). Spontaneous resolution of RS-fluoxetine to a racemic conglomerate upon salt formation with oxalic acid. Crystal Growth and Design, 22( 10), 5966-5973. doi:10.1021/acs.cgd.2c00599
NLM
Carvalho Junior P de S, Diniz LF, Cardoso TFM, Silva CCP da, Ellena J. Spontaneous resolution of RS-fluoxetine to a racemic conglomerate upon salt formation with oxalic acid [Internet]. Crystal Growth and Design. 2022 ; 22( 10): 5966-5973.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1021/acs.cgd.2c00599
Vancouver
Carvalho Junior P de S, Diniz LF, Cardoso TFM, Silva CCP da, Ellena J. Spontaneous resolution of RS-fluoxetine to a racemic conglomerate upon salt formation with oxalic acid [Internet]. Crystal Growth and Design. 2022 ; 22( 10): 5966-5973.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1021/acs.cgd.2c00599
Artigo de periodico
DNA methylation in stress and depression:: from biomarker to therapeutics (2021)
Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Wegener, Sâmia Regiane Lourenço Joca
Source: Acta Neuropsychiatrica. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, BIOMARCADORES, CÉREBRO, METILAÇÃO DE DNA, DEPRESSÃO, REGULAÇÃO GÊNICA, ESTRESSE PSICOLÓGICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALES, Amanda Juliana e GUIMARÃES, Francisco Silveira e WEGENER, Sâmia Regiane Lourenço Joca. DNA methylation in stress and depression:: from biomarker to therapeutics. Acta Neuropsychiatrica, v. 33, n. 5, p. 217-241, 2021Tradução . . Disponível em: https://doi.org/10.1017/neu.2021.18. Acesso em: 16 nov. 2024.
APA
Sales, A. J., Guimarães, F. S., & Wegener, S. R. L. J. (2021). DNA methylation in stress and depression:: from biomarker to therapeutics. Acta Neuropsychiatrica, 33( 5), 217-241. doi:10.1017/neu.2021.18
NLM
Sales AJ, Guimarães FS, Wegener SRLJ. DNA methylation in stress and depression:: from biomarker to therapeutics [Internet]. Acta Neuropsychiatrica. 2021 ; 33( 5): 217-241.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1017/neu.2021.18
Vancouver
Sales AJ, Guimarães FS, Wegener SRLJ. DNA methylation in stress and depression:: from biomarker to therapeutics [Internet]. Acta Neuropsychiatrica. 2021 ; 33( 5): 217-241.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1017/neu.2021.18
Artigo de periodico
Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors (2021)
Arcaro, Carlos Alberto; Assis, Renata Pires; Oliveira, Juliana Oriel; Zanon, Neusa Maria; Paula-Gomes, Silvia; Navegantes, Luiz Carlos Carvalho ; Kettelhut, Isis do Carmo ; Brunetti, Iguatemy Lourenço; Baviera, Amanda Martins
Source: Life Sciences. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, MÚSCULO ESQUELÉTICO, METABOLISMO DE PROTEÍNA, PROTEÍNAS DO TECIDO NERVOSO, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARCARO, Carlos Alberto et al. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors. Life Sciences, v. 278, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2021.119563. Acesso em: 16 nov. 2024.
APA
Arcaro, C. A., Assis, R. P., Oliveira, J. O., Zanon, N. M., Paula-Gomes, S., Navegantes, L. C. C., et al. (2021). Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors. Life Sciences, 278, 1-12. doi:10.1016/j.lfs.2021.119563
NLM
Arcaro CA, Assis RP, Oliveira JO, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut I do C, Brunetti IL, Baviera AM. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors [Internet]. Life Sciences. 2021 ; 278 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2021.119563
Vancouver
Arcaro CA, Assis RP, Oliveira JO, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut I do C, Brunetti IL, Baviera AM. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors [Internet]. Life Sciences. 2021 ; 278 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2021.119563
Artigo de periodico
Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model (2021)
Pinto, Leonardo Santos Ribeiro; Bapat, Priya; Moreira, Fernanda de Lima; Lubetsky, Angelika; Cavalli, Ricardo de Carvalho; Berger, Howard; Lanchote, Vera Lucia ; Koren, Gideon
Source: Pharmaceutical Research. Unidades: FCFRP, FMRP
Subjects: ANTAGONISTAS, FARMACOTERAPIA, ANTIDEPRESSIVOS, PLACENTA, COMPLICAÇÕES NA GRAVIDEZ, ANTI-HISTAMÍNICOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro et al. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model. Pharmaceutical Research, v. 38, n. 4, p. 647-655, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11095-021-03035-7. Acesso em: 16 nov. 2024.
APA
Pinto, L. S. R., Bapat, P., Moreira, F. de L., Lubetsky, A., Cavalli, R. de C., Berger, H., et al. (2021). Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model. Pharmaceutical Research, 38( 4), 647-655. doi:10.1007/s11095-021-03035-7
NLM
Pinto LSR, Bapat P, Moreira F de L, Lubetsky A, Cavalli R de C, Berger H, Lanchote VL, Koren G. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model [Internet]. Pharmaceutical Research. 2021 ; 38( 4): 647-655.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11095-021-03035-7
Vancouver
Pinto LSR, Bapat P, Moreira F de L, Lubetsky A, Cavalli R de C, Berger H, Lanchote VL, Koren G. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model [Internet]. Pharmaceutical Research. 2021 ; 38( 4): 647-655.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11095-021-03035-7
Artigo de periodico
Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action (2021)
Chaves, Yane Costa; Genaro, Karina; Crippa, José Alexandre de Souza ; Cunha, Joice Maria da; Zanoveli, Janaina Menezes
Source: Metabolic Brain Disease. Unidade: FMRP
Subjects: ANSIOLÍTICOS, ANTIDEPRESSIVOS, CANABINOIDES, DIABETES MELLITUS, FARMACOTERAPIA, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Yane Costa et al. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease, v. 36, n. 4, p. 639-652, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11011-020-00667-3. Acesso em: 16 nov. 2024.
APA
Chaves, Y. C., Genaro, K., Crippa, J. A. de S., Cunha, J. M. da, & Zanoveli, J. M. (2021). Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease, 36( 4), 639-652. doi:10.1007/s11011-020-00667-3
NLM
Chaves YC, Genaro K, Crippa JA de S, Cunha JM da, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action [Internet]. Metabolic Brain Disease. 2021 ; 36( 4): 639-652.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11011-020-00667-3
Vancouver
Chaves YC, Genaro K, Crippa JA de S, Cunha JM da, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action [Internet]. Metabolic Brain Disease. 2021 ; 36( 4): 639-652.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11011-020-00667-3
Artigo de periodico
Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment (2021)
Ferreira, Frederico Rogério; Cupido, Alexander; Catalin, Bogdan; Silva Junior, Wilson Araújo da ; Kirchhoff, Frank; Del Bel, Elaine Aparecida ; Guimarães, Francisco Silveira
Source: Neurotoxicity Research. Unidades: FMRP, FORP
Subjects: ASTRÓCITOS, CALMODULINA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Frederico Rogério et al. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment. Neurotoxicity Research, v. 39, n. 3, p. 860-871, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12640-021-00334-0. Acesso em: 16 nov. 2024.
APA
Ferreira, F. R., Cupido, A., Catalin, B., Silva Junior, W. A. da, Kirchhoff, F., Del Bel, E. A., & Guimarães, F. S. (2021). Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment. Neurotoxicity Research, 39( 3), 860-871. doi:10.1007/s12640-021-00334-0
NLM
Ferreira FR, Cupido A, Catalin B, Silva Junior WA da, Kirchhoff F, Del Bel EA, Guimarães FS. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment [Internet]. Neurotoxicity Research. 2021 ; 39( 3): 860-871.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s12640-021-00334-0
Vancouver
Ferreira FR, Cupido A, Catalin B, Silva Junior WA da, Kirchhoff F, Del Bel EA, Guimarães FS. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment [Internet]. Neurotoxicity Research. 2021 ; 39( 3): 860-871.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s12640-021-00334-0
Artigo de periodico
Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A (2021)
Tozatto, Eduardo; Benzi, Jhohann Richard de Lima ; Rocha, Adriana; Coelho, Eduardo Barbosa ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, HIPERTENSÃO, FARMACOCINÉTICA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO, Eduardo et al. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, v. 61, n. 3, p. 319-327, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcph.1745. Acesso em: 16 nov. 2024.
APA
Tozatto, E., Benzi, J. R. de L., Rocha, A., Coelho, E. B., & Lanchote, V. L. (2021). Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, 61( 3), 319-327. doi:10.1002/jcph.1745
NLM
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.1745
Vancouver
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.1745
Artigo de periodico
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors (2021)
Casarotto, Plinio C.; Girych, Mykhailo; Fred, Senem M.; Kovaleva, Vera; Moliner, Rafael; Enkavi, Giray; Biojone, Caroline; Cannarozzo, Cecilia; Sahu, Madhusmita Pryiadrashini; Kaurinkoski, Katja; Brunello, Cecilia A.; Steinzeig, Anna; Winkel, Frederike; Patil, Sudarshan; Vestring, Stefan; Serchov, Tsvetan; Diniz, Cassiano Ricardo Alves Faria; Laukkanen, Liina; Cardon, Iseline; Antila, Hanna; Rog, Tomasz; Piepponen, Timo Petteri; Bramham, Clive R.; Normann, Claus; Lauri, Sari E.; Saarma, Mart; Vattulainen, Ilpo; Castrén, Eero
Source: Cell. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, LINHAGEM CELULAR, COLESTEROL, HIPOCAMPO, CÓRTEX VISUAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASAROTTO, Plinio C. et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell, v. 184, n. 5, p. 1299-1313, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2021.01.034. Acesso em: 16 nov. 2024.
APA
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., et al. (2021). Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell, 184( 5), 1299-1313. doi:10.1016/j.cell.2021.01.034
NLM
Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, Biojone C, Cannarozzo C, Sahu MP, Kaurinkoski K, Brunello CA, Steinzeig A, Winkel F, Patil S, Vestring S, Serchov T, Diniz CRAF, Laukkanen L, Cardon I, Antila H, Rog T, Piepponen TP, Bramham CR, Normann C, Lauri SE, Saarma M, Vattulainen I, Castrén E. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors [Internet]. Cell. 2021 ; 184( 5): 1299-1313.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.cell.2021.01.034
Vancouver
Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, Biojone C, Cannarozzo C, Sahu MP, Kaurinkoski K, Brunello CA, Steinzeig A, Winkel F, Patil S, Vestring S, Serchov T, Diniz CRAF, Laukkanen L, Cardon I, Antila H, Rog T, Piepponen TP, Bramham CR, Normann C, Lauri SE, Saarma M, Vattulainen I, Castrén E. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors [Internet]. Cell. 2021 ; 184( 5): 1299-1313.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.cell.2021.01.034
Artigo de periodico
Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics (2020)
Pinto, Leonardo Santos Ribeiro; Moreira, Fernanda de Lima ; Nardotto, Glauco Henrique Balthazar ; Cavalli, Ricardo de Carvalho ; Moisés, Elaine Christine Dantas ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: Pharmaceutical Research. Unidades: FCFRP, FMRP
Subjects: ANTIDEPRESSIVOS, FARMACOCINÉTICA, GRAVIDEZ, ESTUDOS DE CASOS E CONTROLES, MUCOSA INTESTINAL, ANTI-HISTAMÍNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro et al. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, v. 37, n. 7, 2020Tradução . . Disponível em: https://doi.org/10.1007/s11095-020-02854-4. Acesso em: 16 nov. 2024.
APA
Pinto, L. S. R., Moreira, F. de L., Nardotto, G. H. B., Cavalli, R. de C., Moisés, E. C. D., Duarte, G., & Lanchote, V. L. (2020). Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, 37( 7). doi:10.1007/s11095-020-02854-4
NLM
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11095-020-02854-4
Vancouver
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11095-020-02854-4
Parte de monografia/livro
Cannabidiol in mental health disorders (2019)
Campos, Alline Cristina de; Gomes, Felipe Villela ; Wegener, Sâmia Regiane Lourenço Joca ; Guimarães, Francisco Silveira
Source: Cannabis as medicine. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, ANSIOLÍTICOS, ANTIDEPRESSIVOS, SAÚDE MENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Alline Cristina de et al. Cannabidiol in mental health disorders. Cannabis as medicine. Tradução . Boca Raton: CRC Press, 2019. . Disponível em: https://repositorio.usp.br/directbitstream/fe7b528c-8a6e-42ea-9fc1-595ec0bf4f01/003012109.PDF. Acesso em: 16 nov. 2024.
APA
Campos, A. C. de, Gomes, F. V., Wegener, S. R. L. J., & Guimarães, F. S. (2019). Cannabidiol in mental health disorders. In Cannabis as medicine. Boca Raton: CRC Press. Recuperado de https://repositorio.usp.br/directbitstream/fe7b528c-8a6e-42ea-9fc1-595ec0bf4f01/003012109.PDF
NLM
Campos AC de, Gomes FV, Wegener SRLJ, Guimarães FS. Cannabidiol in mental health disorders [Internet]. In: Cannabis as medicine. Boca Raton: CRC Press; 2019. [citado 2024 nov. 16 ] Available from: https://repositorio.usp.br/directbitstream/fe7b528c-8a6e-42ea-9fc1-595ec0bf4f01/003012109.PDF
Vancouver
Campos AC de, Gomes FV, Wegener SRLJ, Guimarães FS. Cannabidiol in mental health disorders [Internet]. In: Cannabis as medicine. Boca Raton: CRC Press; 2019. [citado 2024 nov. 16 ] Available from: https://repositorio.usp.br/directbitstream/fe7b528c-8a6e-42ea-9fc1-595ec0bf4f01/003012109.PDF
Artigo de periodico
Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women (2019)
Carvalho, Daniela Miarelli; Lanchote, Vera Lucia; Filgueira, Gabriela Campos de Oliveira; Nardotto, Glauco Henrique Balthazar; Duarte, Geraldo; Cavalli, Ricardo Carvalho; Moisés, Elaine Christine Dantas
Source: Clinical Pharmacology and Therapeutics. Unidades: FCFRP, FMRP
Subjects: FARMACOCINÉTICA CLÍNICA, PLACENTA, ANTIDEPRESSIVOS, GESTANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Daniela Miarelli et al. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, v. 105, n. 4, p. 1003-1008, 2019Tradução . . Disponível em: https://doi.org/10.1002/cpt.1263. Acesso em: 16 nov. 2024.
APA
Carvalho, D. M., Lanchote, V. L., Filgueira, G. C. de O., Nardotto, G. H. B., Duarte, G., Cavalli, R. C., & Moisés, E. C. D. (2019). Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, 105( 4), 1003-1008. doi:10.1002/cpt.1263
NLM
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/cpt.1263
Vancouver
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/cpt.1263
Artigo de periodico
Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder (2019)
Vattimo, Edoardo F. Q; Barros, Vivian B; Requena, Guaraci; Sato, Joao R; Fatori, Daniel; Miguel filho, Euripedes Constantino ; Shavitt, Roseli G; Hoexter, Marcelo Q; Batistuzzo, Marcelo C
Source: European child & adolescent psychiatry. Unidade: FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO, ANTIDEPRESSIVOS, TERAPIA COGNITIVA, RESSONÂNCIA MAGNÉTICA, SISTEMA NERVOSO CENTRAL, CÉREBRO, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VATTIMO, Edoardo F. Q et al. Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder. European child & adolescent psychiatry, v. 28, n. 12, p. 1607-1617, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00787-019-01320-w. Acesso em: 16 nov. 2024.
APA
Vattimo, E. F. Q., Barros, V. B., Requena, G., Sato, J. R., Fatori, D., Miguel filho, E. C., et al. (2019). Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder. European child & adolescent psychiatry, 28( 12), 1607-1617. doi:10.1007/s00787-019-01320-w
NLM
Vattimo EFQ, Barros VB, Requena G, Sato JR, Fatori D, Miguel filho EC, Shavitt RG, Hoexter MQ, Batistuzzo MC. Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder [Internet]. European child & adolescent psychiatry. 2019 ; 28( 12): 1607-1617.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00787-019-01320-w
Vancouver
Vattimo EFQ, Barros VB, Requena G, Sato JR, Fatori D, Miguel filho EC, Shavitt RG, Hoexter MQ, Batistuzzo MC. Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder [Internet]. European child & adolescent psychiatry. 2019 ; 28( 12): 1607-1617.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00787-019-01320-w

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration